FindTrial
Sign In

The analysis for the perioperative efficacy of dexmedetomidine on modified electroconvulsive Therapy

The analysis for the perioperative efficacy of dexmedetomidine on modified electroconvulsive therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006463
Enrollment
Unknown
Registered
2015-05-28
Start date
2015-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disease

Interventions

Group 1:dexmedetomidine 0.5ug/Kg
Group 2:dexmedetomidine 0.2ug/Kg
Control Group:saline

Sponsors

Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients anticipated the research and signed the informed consent voluntarily; 2. Patients treated in our hospital with depression, schizophrenia and bipolar disorder and underwent MECT for the first time; 3. From 16-55 years old. Sex is not limited; 4. Patients without any psychotic drugs before MECT.

Exclusion criteria

Exclusion criteria: 1. Patients refused to anticipate; 2. Patients suffered from the serious diseases of important organs, including liver and kidney dysfunction, brain organic disease, NYHA>=III dysfunction of blood coagulation, sick sinus syndrome, bradycardia(HR<55bpm), atrioventricular block of degree II and III; 3. Dexmedetomidine contraindication.

Design outcomes

Primary

MeasureTime frame
hemodynamics;Score of mental symptom;—

Secondary

MeasureTime frame
Uncomfortable feeling after MECT;—

Countries

China

Contacts

Public ContactZhou Shaoli
shaolizhou@139.com+86 13610272308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026